Scilex Ownership | Who Owns Scilex?
Scilex Ownership Summary
Scilex is owned by 2.87% institutional investors, 17.56% insiders, and 79.57% retail investors. Vanguard group is the largest institutional shareholder, holding 2.54% of SCLX shares. SPDR® S&P Biotech ETF is the top mutual fund, with 3.24% of its assets in Scilex shares.
SCLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Scilex | 2.87% | 17.56% | 79.57% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Drug Manufacturers - General Stocks | 26.93% | 1.98% | 71.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 295.02K | 2.54% | $3.60M |
| Blackrock funding, inc. /de | 98.33K | 0.85% | $1.20M |
| Armistice capital | 66.00K | 0.57% | $1.30M |
| Renaissance | 38.46K | 0.33% | $469.26K |
| State street | 33.43K | 0.29% | $657.96K |
| Citigroup | 19.85K | 0.17% | $242.12K |
| Ashton thomas private wealth | 17.99K | 0.15% | $219.47K |
| Northern trust | 15.16K | 0.13% | $298.29K |
| Morgan stanley | 14.61K | 0.13% | $178.19K |
| Norges bank | 13.64K | 0.12% | $80.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Donald l. hagan | 11.87K | 0.11% | $233.66K |
| Armistice capital | 66.00K | 0.02% | $1.30M |
| Ashton thomas private wealth | 17.99K | 0.01% | $219.47K |
| Creative financial designs inc /adv | 1.85K | 0.00% | $22.61K |
| Versant capital management | 761.00 | 0.00% | $9.28K |
| Renaissance | 38.46K | 0.00% | $469.26K |
| Activest wealth management | 302.00 | 0.00% | $3.68K |
| Tower research capital llc (trc) | 1.06K | 0.00% | $20.82K |
| Quantinno capital management lp | 10.94K | 0.00% | $215.36K |
| Mcf advisors | 474.00 | 0.00% | $5.78K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 66.00K | 0.02% | 66.00K |
| State street | 33.43K | - | 21.55K |
| Citigroup | 19.85K | 0.00% | 19.85K |
| Renaissance | 38.46K | 0.00% | 19.30K |
| Northern trust | 15.16K | - | 15.16K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -1.04M |
| Murchinson | - | - | -663.71K |
| Janus henderson group | - | - | -542.31K |
| Heights capital management | - | - | -221.87K |
| Lmr partners llp | - | - | -213.37K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Armistice capital | 66.00K | 0.02% | 66.00K | $1.30M |
| Citigroup | 19.85K | 0.00% | 19.85K | $242.12K |
| Northern trust | 15.16K | - | 15.16K | $298.29K |
| Norges bank | 13.64K | - | 13.64K | $80.36M |
| Donald l. hagan | 11.87K | 0.11% | 11.87K | $233.66K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -1.00 |
| First command advisory services | -2.00 |
| Legal & general group | -5.00 |
| Wealthspire advisors | -6.00 |
| Pnc financial services group | -9.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 32 | -60.00% | 333,601 | -56.10% | 2 | 6.69% | 5 | -86.11% | 7 | -53.33% |
| Sep 30, 2025 | 34 | -46.03% | 315,750 | -49.04% | 2 | 9.54% | 13 | -61.76% | 3 | -89.66% |
| Jun 30, 2025 | 61 | -21.79% | 619,353 | -98.61% | 5 | 4.44% | 33 | 43.48% | 28 | 64.71% |
| Mar 31, 2025 | 78 | -20.41% | 44,442,233 | 6.91% | 10 | 1.02% | 24 | -38.46% | 16 | 33.33% |
| Dec 31, 2024 | 99 | 6.45% | 49,076,082 | 45.69% | 38 | 5.49% | 40 | 25.00% | 12 | -20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| SPDR® S&P Biotech ETF | 169.67K | 3.24% | - |
| Vanguard Total Stock Mkt Idx Inv | 176.62K | 2.51% | 6.82K |
| Vanguard Institutional Extnd Mkt Idx Tr | 76.51K | 1.09% | - |
| iShares Russell 2000 ETF | 40.87K | 0.74% | - |
| Vanguard Balanced Index Inv | 44.34K | 0.64% | - |
| Fidelity Extended Market Index | 24.41K | 0.35% | -201.00 |
| Direxion Daily S&P Biotech Bull 3X ETF | 17.72K | 0.32% | - |
| iShares Russell 2000 Value ETF | 576.36K | 0.31% | - |
| JPM Thematics Genetic Thrps C2 Acc USD | 397.32K | 0.30% | - |
| Blackrock Extended Mkt Fund CF | 20.04K | 0.28% | 20.04K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 26, 2025 | Scilex Holding Co | - | Sell | $2.77M |
| Dec 30, 2025 | Scilex Holding Co | - | Sell | $5.21M |
| Dec 29, 2025 | Scilex Holding Co | - | Sell | $4.79M |
| Dec 18, 2024 | SHAH JAISIM | See Remarks | Buy | $13.80K |
| Oct 31, 2024 | Ji Henry | Executive Chairperson | Buy | $8.35K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 3 |
| 2025 Q1 | - | - |
| 2024 Q4 | 10 | - |
| 2024 Q3 | - | - |
| 2024 Q2 | 5 | - |
SCLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools